{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:43:14Z","timestamp":1787010194768,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>To clarify mechanisms of ineffective erythropoiesis on iron metabolism, studies on erythroid factors that regulating hepcidin suppression have been carried out. The aim of the current study is to identify associations between erythropoiesis and iron homeostasis parameters in \u03b2-thalassemias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This study consisted of 83 subjects: 21 thalassemia major (TM), 20 thalassemia intermedia (TI), 20 thalassemia trait (TT), and 22 healthy subjects (HS). Erythroferrone (ERFE), hepcidin, growth differentiation factor-15 (GDF15), erythropoietin (EPO), and iron status parameters were measured.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Our results showed that TM and TI patients had higher hepcidin than the TT and control groups. The hepcidin\/ferritin in TM patients was significantly lower than the other groups. GDF15 in TM and TI patients was significantly higher than in the TT and control groups. Also, TI group had significantly higher ERFE concentration and EPO activity when compared with the TM, TT, and HS groups. EPO activity showed positive correlation with ERFE and GDF15 concentrations. We could not find any correlation between ERFE and hepcidin concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>ERFE may be one of the parameters used to demonstrate erythropoietic activity level in thalassemias. More detailed studies are needed to clarify the role of ERFE in iron metabolism in the patients with thalassemias.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mph.0000000000002046","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T02:12:34Z","timestamp":1608862354000},"page":"186-192","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Erythropoiesis and Iron Parameters in Transfusion-dependent and Nontransfusion-dependent Thalassemias"],"prefix":"10.1097","volume":"43","author":[{"given":"Zeynep","family":"Ozturk","sequence":"first","affiliation":[{"name":"Medical Biochemistry"},{"name":"Pediatric Hematology, Faculty of Medicine, Akdeniz University, Antalya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadet","family":"Gumuslu","sequence":"additional","affiliation":[{"name":"Medical Biochemistry"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koray","family":"Yalcin","sequence":"additional","affiliation":[{"name":"Medical Park G\u00f6ztepe Hospital, Pediatric Bone Marrow Transplantation Centre, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alphan","family":"Kupesiz","sequence":"additional","affiliation":[{"name":"Pediatric Hematology, Faculty of Medicine, Akdeniz University, Antalya"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,12,22]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/10715762.2015.1004327","article-title":"Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress","volume":"49","author":"Ozturk","year":"2015","journal-title":"Free Radic Res"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.apjtm.2016.07.035","article-title":"Iron dysregulation in beta-thalassemia","volume":"9","author":"Leecharoenkiat","year":"2016","journal-title":"Asian Pac J Trop Med"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/blood-2016-12-759423","article-title":"Smad1\/5 is required for erythropoietin-mediated suppression of hepcidin in mice","volume":"130","author":"Wang","year":"2017","journal-title":"Blood"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fphar.2014.00104","article-title":"Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis","volume":"5","author":"Core","year":"2014","journal-title":"Front Pharmacol"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s00277-014-2113-1","article-title":"Association of growth differentiation factor 15 (GDF15) polymorphisms with serum GDF15 and ferritin levels in beta-thalassemia","volume":"93","author":"Athiyarath","year":"2014","journal-title":"Ann Hematol"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1629","article-title":"High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin","volume":"13","author":"Tanno","year":"2007","journal-title":"Nat Med"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1537-2995.2010.02601.x","article-title":"Expression of growth differentiation factor 15 is not elevated in individuals with iron deficiency secondary to volunteer blood donation","volume":"50","author":"Tanno","year":"2010","journal-title":"Transfusion"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2141.2009.07961.x","article-title":"Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia","volume":"148","author":"Theurl","year":"2010","journal-title":"Br J Haematol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MOH.0000000000000132","article-title":"New insights into iron regulation and erythropoiesis","volume":"22","author":"Kim","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bcmd.2011.07.005","article-title":"Levels of growth differentiation factor-15 are high and correlate with clinical severity in transfusion-independent patients with beta thalassemia intermedia","volume":"47","author":"Musallam","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bcmd.2015.06.001","article-title":"Growth differentiation factor-15 in children and adolescents with thalassemia intermedia: relation to subclinical atherosclerosis and pulmonary vasculopathy","volume":"55","author":"Tantawy","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat Genet"},{"key":"R13-20250804","first-page":"E24","article-title":"The erythroid factor erythroferrone and its role in iron homeostasis","volume":"88","author":"Kautz","year":"2013","journal-title":"Am J Hematol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood-2015-07-658419","article-title":"Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of beta-thalassemia","volume":"126","author":"Kautz","year":"2015","journal-title":"Blood"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood-2017-04-777987","article-title":"Immunoassay for human serum erythroferrone","volume":"130","author":"Ganz","year":"2017","journal-title":"Blood"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00277-019-03882-w","article-title":"Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia","volume":"99","author":"El-Gamal","year":"2020","journal-title":"Ann Hematol"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3324\/haematol.2011.056119","article-title":"Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis","volume":"97","author":"Mastrogiannaki","year":"2012","journal-title":"Haematologica"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1182\/blood-2006-06-028787","article-title":"Suppression of hepcidin during anemia requires erythropoietic activity","volume":"108","author":"Pak","year":"2006","journal-title":"Blood"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/bjh.14373","article-title":"Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions","volume":"176","author":"Porter","year":"2017","journal-title":"Br J Haematol"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1182\/blood-2004-12-4844","article-title":"Hepcidin in iron overload disorders","volume":"105","author":"Papanikolaou","year":"2005","journal-title":"Blood"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3324\/haematol.10842","article-title":"Liver iron concentrations and urinary hepcidin in beta-thalassemia","volume":"92","author":"Origa","year":"2007","journal-title":"Haematologica"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s12098-017-2375-4","article-title":"Serum hepcidin as a diagnostic marker of severe iron overload in beta-thalassemia major","volume":"84","author":"Kaddah","year":"2017","journal-title":"Indian J Pediatr"},{"key":"R23-20250804","first-page":"809","article-title":"The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major","volume":"91","author":"Kattamis","year":"2006","journal-title":"Haematologica"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/pbc.20616","article-title":"Urinary hepcidin in congenital chronic anemias","volume":"48","author":"Kearney","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s13312-018-1408-z","article-title":"Serum hepcidin levels in children with beta thalassemia major","volume":"55","author":"Jagadishkumar","year":"2018","journal-title":"Indian Pediatr"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bcmd.2014.08.006","article-title":"Growth differentiation factor 15 expression and regulation during erythroid differentiation in non-transfusion dependent thalassemia","volume":"54","author":"Ronzoni","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"R27-20250804","first-page":"184","article-title":"Growth differentiation factor 15 in erythroid health and disease","volume":"17","author":"Tanno","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"e65549","DOI":"10.1371\/journal.pone.0065549","article-title":"Adaptive induction of growth differentiation factor 15 attenuates endothelial cell apoptosis in response to high glucose stimulus","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"490842","DOI":"10.1155\/2015\/490842","article-title":"GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective","volume":"2015","author":"Adela","year":"2015","journal-title":"J Diabetes Res"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2018-06-857995","article-title":"Erythroferrone inhibits the induction of hepcidin by BMP6","volume":"132","author":"Arezes","year":"2018","journal-title":"Blood"},{"key":"R31-20250804","first-page":"4504302","article-title":"Erythropoiesis and iron homeostasis in non-transfusion-dependent thalassemia patients with extramedullary hematopoiesis","volume":"2019","author":"Huang","year":"2019","journal-title":"BioMed Res Int"},{"key":"R32-20250804","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1002\/ajh.24636","article-title":"EPO and hepcidin plasma concentrations in blood donors and beta-thalassemia intermedia are not related to commercially tested plasma ERFE concentrations","volume":"92","author":"Schotten","year":"2017","journal-title":"Am J Hematol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:11:12Z","timestamp":1754338272000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,22]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002046","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,22]]},"assertion":[{"value":"2020-07-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}